Exploring Real-World HER2-Low Data in Early-Stage Triple-Negative Breast Cancer: Insights and Implications.

Jesse Lopes da SilvaGiselle de Souza CarvalhoLucas Zanetti de AlbuquerqueFabiana Resende RodriguesPriscila Valverde FernandesDaniel KischinhevskyAndreia Cristina de Melo

Published in: Breast cancer (Dove Medical Press) (2023)

The findings of this study suggest that, in early-stage TNBC, the clinical behavior and survival outcomes of the HER2-low subgroup may not differ significantly from those of the HER2-zero subgroup.

Keyphrases

early stage
electronic health record
big data
phase iii
randomized controlled trial
open label
radiation therapy
locally advanced